Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2

Young-Kwan LEE; Hoon-Bok LEE; Dong-Mi SHIN; Min-Jueng KANG; Eugene-C YI; Seungjoo NOH; Jaewoo LEE; Chulbom LEE; Chang-Ki MIN; Eun-Young CHOI.
Experimental & Molecular Medicine ; : e121-2014.
Artículo en Inglés | WPRIM | ID: wpr-37642

Documentos relacionados

  1. Increasing the bioactivity of kynurenine by ultraviolet irradiation via resonance energy transfer in vitro.
  2. Macrophage de novo NAD<sup>+</sup> synthesis specifies immune function in aging and inflammation.
  3. Indoleamine 2,3-dioxygenase 1 regulates cell permissivity to astrovirus infection.
  4. Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2.
  5. IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer.
  6. The Role of the Placental Enzyme Indoleamine 2,3-Dioxygenase in Normal and Abnormal Human Pregnancy.
  7. Tryptophan depletion results in tryptophan-to-phenylalanine substitutants.
  8. Aberrant NAD synthetic flux in podocytes under diabetic conditions and effects of indoleamine 2,3-dioxygenase on promoting de novo NAD synthesis.
  9. Gestational Insulin Resistance Is Mediated by the Gut Microbiome-Indoleamine 2,3-Dioxygenase Axis.
  10. Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling.